Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bohler, J.
Right arrow Articles by Horl, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohler, J.
Right arrow Articles by Horl, W. H.

Journal of the American Society of Nephrology, Vol 7, 234-241, Copyright © 1996 by American Society of Nephrology


REGULAR ARTICLES

Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation

J Bohler, P Schollmeyer, B Dressel, G Dobos and WH Horl
Department of Nephrology, University of Freiburg, Germany.

Neutropenia and degranulation of neutrophils during hemodialysis with cellulosic membranes have been linked to complement activation, whereas in the synthetic polymethyl methacrylate (PMMA) membrane, degranulation occurs without notable complement activation. The mechanisms of neutrophil degranulation under these conditions have not yet been elucidated. Ionized calcium is an important prerequisite of granulocyte activation during in vitro blood contact with both types of artificial surfaces. This study compared the effect of normal ionized calcium during heparin anticoagulation with the effect of extracorporeal calcium depletion during regional citrate anticoagulation on activation of blood components. Because ionized calcium is reduced only in the extra-corporeal circuit, citrate anticoagulation in addition helps to differentiate between extracorporeal and systemic activation phenomena. Twelve chronic hemodialysis patients were dialyzed with polymethyl methacrylate (PMMA, 16 treatments) or cuprophane (CUP, 16 treatments) membranes either during regional citrate anticoagulation or while anticoagulated with heparin. During hemodialysis with CUP, anticoagulation with citrate significantly reduced neutropenia, C3a levels, and lactoferrin release. Elastase concentrations, however, were not reduced by citrate, probably because elastase release occurred not locally in the cuprophane dialyzer, but mostly in the systemic circulation of the patient. PMMA did not elevate C3a levels, and neutropenia was only mild. Both parameters were not influenced by citrate anti-coagulation. However, PMMA profoundly induced elastase and lactoferrin release during heparin anti-coagulation. Depletion of ionized calcium markedly reduced PMMA-mediated neutrophil degranulation in the extracorporeal circuit. The results indicate that ionized calcium is a requirement for neutrophil degranulation during hemodialysis. In PMMA membranes, neutrophil degranulation occurs independent of high complement levels, occurs at least partially inside the dialyzer, and requires the presence of ionized calcium in the extracorporeal circuit. In cuprophane membranes, degranulation was uncoupled from neutropenia and did not correlate with the degree of complement activation. Even in cuprophane dialysis, degranulation of secondary granules was markedly dependent on ionized calcium levels in the extracorporeal circuit.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Gritters, P. Borgdorff, M. P. C. Grooteman, M. Schoorl, M. Schoorl, P. C. M. Bartels, G.-J. Tangelder, and M. J. Nube
Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2911 - 2917.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. S. Rinder, M. J. Smith, H. M. Rinder, D. N. Cortright, R. M. Brodbeck, J. E. Krause, and B. R. Smith
Leukocyte Effects of C5a-Receptor Blockade During Simulated Extracorporeal Circulation
Ann. Thorac. Surg., January 1, 2007; 83(1): 146 - 152.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Gritters, M. P. C. Grooteman, M. Schoorl, M. Schoorl, P. C. M. Bartels, P. G. Scheffer, T. Teerlink, C. G. Schalkwijk, M. Spreeuwenberg, and M. J. Nube
Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 153 - 159.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. H. Horl
Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S62 - 71.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Schmaldienst and W. H. Horl
Degranulation of polymorphonuclear leukocytes by dialysis membranes--the mystery clears up?
Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1909 - 1910.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Leitienne, D. Fouque, D. Rigal, P. Adeleine, M.-C. Trzeciak, and M. Laville
Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept
Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1631 - 1637.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. MEMOLI, L. MARZANO, V. BISESTI, M. ANDREUCCI, and B. GUIDA
Hemodialysis-Related Lymphomononuclear Release of Interleukin-12 in Patients with End-Stage Renal Disease
J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2171 - 2176.
[Abstract] [Full Text]


Home page
NEJMHome page
R. Apsner, W. Druml, C.-y. Hsu, R. Palsson, and J. L. Niles
More on Anticoagulation for Continuous Hemofiltration
N. Engl. J. Med., January 8, 1998; 338(2): 131 - 132.
[Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP